Belgium
Advent completes Corialis SBO
Deal marks Corialis's fourth stint under private equity ownership
Gimv acquires Europlasma
Gimv takes majority stake in the business
PMV invests in Bubble Post
Company to expand internationally in 2015
JC Flowers' Fidea sold to Anbang
Firm acquired Fidea in October 2011 from KBC
Qbic et al. invest €2m in Biogazelle
Company claims to have experienced 70% annual growth rate
Gimv sells Trustteam to Naxicap
Naxicap will support the company in entering French market
Benelux sees summer uptick
Despite the summer break the Benelux region has seen strong dealflow
Reiten sells Blueway to Ardian's NHV
Combined company will have turnover of $270m
D2E backs Contraload MBO
Deal marks third investment by D2E
Advent to buy Corialis from Sagard, Ergon
Deal will mark fourth private equity buyout for the company
Gimv exits dcinex in €26m deal
Transaction includes cash and share-swap
Belgian VCs fail to benefit from country's hidden wealth
Belgian venture funds should be trying to access private wealth
Bencis acquires Morubel
Company split from bankrupt parent earlier this year
Waterland exits P Lemmens in trade sale
Buyer purchases 90% stake in company
Qbic and PMV invest €500,000 in Pharmafluidics
The two firms split the funding equally
Waterland invests in Bosteels
Family business is currently under seventh-generation management
PE-backed Ontex raises €518.6m in IPO
Flotation gives company enterprise value of c€1.87bn - 10.7x EBITDA
Gilde hires Waterland's Van den Weghe as investment director
Frédéric Van den Weghe, Gilde
Vendis makes first exit with Zeb sale
Zeb was Vendis's first investment
PE-backed Ontex valued at up to €1.35bn in upcoming IPO
Offering will result in partial exit for PE backers
Alven et al. invest €1m in Textmaster
Company hopes to secure third funding round by year-end
Gimv sells listed Barco stake
Final exit after holding period of more than 30 years
Benelux: Foreign investors boost higher value activity
Benelux attracting foreign investment
Cartagenia raises €4.25m from Capricorn et al.
Company to branch into oncology and reproductive health sectors